文献速递瓣膜病与结构性心脏病

复发性感染性心内膜炎的临床特征与结局

Clinical profile and outcome of recurrent infective endocarditis.
PubMed 文献 · Heart · 2022-10-13

基于欧洲156中心EURO-ENDO注册研究,比较267例复发性与2839例初发性感染性心内膜炎患者,采用倾向性评分匹配。复发性IE中再感染占79.4%、复发占20.6%,金黄色葡萄球菌最常见,三尖瓣受累更多;两组院内及院后死亡率无差异,复发性IE中静脉药瘾者院内死亡率更高。

要点

  • 复发性IE中再感染占79.4%,复发仅占20.6%。
  • 复发性IE三尖瓣受累比例20.3%高于初发性14.1%(p=0.012)。
  • 两组院内及院后死亡率无差异,预后不良预测因素相似。

核心结论

  • 复发性与初发性感染性心内膜炎患者院内及1年死亡率相似,且共享相似的预后不良预测因素。
  • 复发性IE中静脉药瘾患者院内死亡率更高。

研究设计与样本

  • 基于EURO-ENDO注册研究(156个中心)的观察性研究,纳入3106例感染性心内膜炎患者。
  • 复发性IE定义为既往IE发作后再次发生,其中≤6个月为复发,>6个月为再感染。
  • 采用倾向性评分匹配比较复发性与初发性IE。

主要发现

  • 共纳入3106例患者,初发性IE 2839例(91.4%,平均年龄59.4±18.1岁,男性68.3%),复发性IE 267例(8.6%,平均年龄58.1±17.7岁,男性74.9%)。
  • 复发性IE中静脉药瘾者占13.2%,66.4%有瓣膜修复或置换,三尖瓣受累20.3%高于初发性IE的14.1%(p=0.012)。
  • 初发性IE主动脉瓣受累45.6%,复发性IE为39.5%(p=0.061)。
  • 复发性IE中再感染占79.4%,复发占20.6%;金黄色葡萄球菌为两组最常见微生物(p=0.207)。
  • 两组院内及院后死亡率无差异;复发性IE中静脉药瘾者院内死亡率更高。

关键数值与推荐

  • 复发性IE分类:复发为IE发生于前次发作后≤6个月,再感染为>6个月。
  • 预后不良的独立预测因素包括心源性休克和感染性休克、瓣膜病变严重程度及有手术指征时未行手术,在复发性与初发性IE中相似。

临床怎么用

  • 复发性IE的治疗策略可参考初发性IE,重点关注心源性休克、感染性休克、瓣膜病变严重程度及手术指征。
  • 对复发性IE中的静脉药瘾患者应警惕更高的院内死亡风险。
  • 复发性IE更常累及三尖瓣,初发性IE更常累及主动脉瓣,影像学评估时需注意。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Purpose of this study is to compare the clinical course and outcome of patients with recurrent versus first-episode infective endocarditis (IE). METHODS: Patients with recurrent and first-episode IE enrolled in the EUROpean ENDOcarditis (EURO-ENDO) registry including 156 centres were identified and compared using propensity score matching. Recurrent IE was classified as relapse when IE occurred ≤6 months after a previous episode or reinfection when IE occurred >6 months after the prior episode. RESULTS: 3106 patients were enrolled: 2839 (91.4%) patients with first-episode IE (mean age 59.4 (±18.1); 68.3% male) and 267 (8.6%) patients with recurrent IE (mean age 58.1 (±17.7); 74.9% male). Among patients with recurrent IE, 13.2% were intravenous drug users (IVDUs), 66.4% had a repaired or replaced valve with the tricuspid valve being more frequently involved compared with patients with first-episode IE (20.3% vs 14.1%; p=0.012). In patients with a first episode of IE, the aortic valve was more frequently involved (45.6% vs 39.5%; p=0.061). Recurrent relapse and reinfection were 20.6% and 79.4%, respectively. Staphylococcus aureus was the microorganism most frequently observed in both groups (p=0.207). There were no differences in in-hospital and post-hospitalisation mortality between recurrent and first-episode IE. In patients with recurrent IE, in-hospital mortality was higher in IVDU patients. Independent predictors of poorer in-hospital and 1-year outcome, including the occurrence of cardiogenic and septic shock, valvular disease severity and failure to undertake surgery when indicated, were similar for recurrent and first-episode IE. CONCLUSIONS: In-hospital and 1-year mortality was similar in patients with recurrent and first-episode IE who shared similar predictors of poor outcome.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Citro R, Chan KL, Miglioranza MH, et al. Clinical profile and outcome of recurrent infective endocarditis. Heart. 2022. PMID: 35641178. doi:10.1136/heartjnl-2021-320652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。